SCHEMBL24290488

SCHEMBL24290488

CC1CNc2cc(Br)ccc2N1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 3/20 0.42
ADRA2A P08913 2/20 0.42
ADRA2B P18089 2/20 0.42
ADRA2C P18825 2/20 0.42
HTR2A P28223 2/20 0.40
HTR2C P28335 2/20 0.40
HTR2B P41595 2/20 0.40
NPC1 O15118 1/20 0.39
LMNA P02545 1/20 0.39
RAB9A P51151 1/20 0.39
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
ASIC3 Q9UHC3 1/20 0.34
MAPKAPK2 P49137 1/20 0.34
SIGMAR1 Q99720 1/20 0.33
BRD4 O60885 1/20 0.33
CMA1 P23946 1/20 0.33
AHR P35869 1/20 0.33
SLC6A4 P31645 2/20 0.33
ALOX5 P09917 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16722791 1.00 PNMT (0.42) PNMTADRA2AADRA2BADRA2CHTR2A
SCHEMBL30570974 0.79 CYP1A2 (0.38) HTR2AHTR2CHTR2BNPC1RAB9A
SCHEMBL29070709 0.79 CYP1A2 (0.38) HTR2AHTR2CHTR2BNPC1RAB9A
SCHEMBL29004257 0.79 HTR2C (0.33) HTR2AHTR2CHTR2BNPC1LMNA
SCHEMBL29004258 0.79 HTR2C (0.33) HTR2AHTR2CHTR2BNPC1LMNA
SCHEMBL12077604 0.78 NPC1 (0.47) PNMTADRA2AADRA2BADRA2CHTR2A
SCHEMBL12077602 0.78 NPC1 (0.47) PNMTADRA2AADRA2BADRA2CHTR2A
SCHEMBL15508323 0.78 HTR2C (0.40) ADRA2AADRA2BADRA2CHTR2AHTR2C
SCHEMBL16722790 0.78 BRD4 (0.33) MAPKAPK2BRD4
SCHEMBL29004248 0.78 HTR2C (0.40) ADRA2AADRA2BADRA2CHTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022073469-A1 COMPOUNDS AND METHODS OF TREATING CANCERS CULLGEN (SHANGHAI) , INC. (CN) 2022-04-14 WO disclosed